← Leaderboards
Jesse Mischa McFarland
Shasqi, Inc.
$2,546,903
Attributed
$5,093,805
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2023–25$5M$3.8M$2.5M$1.3M$0
'23
'24
'25
Funding mix
By agency
NIH$5,093,805 · 3
By mechanism
R44$5,093,805 · 3
Top collaborators
- Jose M Mejia Oneto5 shared
Others in their field
Other Rising Stars on “Drug Kinetics”
- Kevin V Grimes · Stanford University$14,783,804
- Heinz Ernst Moser · University Of Texas Med Br Galveston$13,657,841
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
- Alexander Kolykhalov · Emory University$8,116,465
Research focus
Drug KineticsEffectivenessDose LimitingDrug DevelopmentClinicAdverse Drug EventDoseConjugating AgentDesignDrug CandidateAntibodiesAccelerationAntibody-Drug ConjugatesAntigensAntigen TargetingCostBiopolymersCancer ModelAttenuatedChemistryCyclooctenesDoxorubicinBiologyFailure
Grant awards (5)
CEACAM5-targeted activation of potent chemotherapeutics via bioorthogonal click chemistry$1,094,189
R44 · FY2025 · CA
Antigen-targeted activation of Topo1 inhibitors via click chemistry$431,859
R44 · FY2025 · CA
Antigen-targeted activation of Topo1 inhibitors via click chemistry$1,568,070
R44 · FY2024 · CA
Antibody-guided localized activation of bioorthogonal protodrugs via click chemistry$1,217,955
R44 · FY2024 · CA
Antibody-guided localized activation of bioorthogonal protodrugs via click chemistry$781,732
R44 · FY2023 · CA